LANCASTER, Ohio (November 21, 2011) – Fairfield Medical Center’s deep vein thrombosis (DVT) interventional program is being used as a model for hospitals developing DVT programs.
The program at FMC has grown immensely in less than two years and Covidien, the manufacturer of the Trellis® Peripheral Infusion System that FMC uses, wants FMC’s program to be an example.
“Our DVT treatment volumes have been growing steadily quarter after quarter and we anticipate this trend to continue as patients from the entire Southeast Ohio region are sent to FMC,” said Dr. Krishna Mannava, a vascular and endovascular surgeon at FMC. “Covidien has noticed and wants to use FMC as a model for other small to medium-sized hospitals in developing DVT treatment programs.”
DVT is a condition where a thrombus (a blood clot) forms in a deep vein in the body—usually in the legs. It can be serious because the blood clot can break loose, causing a pulmonary embolism, a condition where the blood clot lodges in the lung.
Dr. Mannava says there are many advantages to treating DVT proactively. FMC utilizes a collaborative effort of the vascular interventional radiology department to get rid of the clot before it causes additional problems.
“Traditional use of anticoagulation (blood thinners) to treat DVT has not been ideal and the addition of endovascular therapy has allowed more aggressive intervention,” Dr. Mannava said.
Dr. Mannava is a member of FMC’s Dr. Gordon B. Snider Cardiovascular Institute and serves on the institute’s physician committee that is developing hospital protocols for the diagnosis and treatment of DVT. “These protocols will make sure that all DVT patients receive what is considered best practice medicine when receiving care at Fairfield Medical Center,” Dr. Mannava explained.
Dr. Mannava spoke Nov. 1-5 at Covidien’s national sales meeting about the program. Covidien is a global healthcare products leader.
Fairfield Medical Center’s vascular surgeons and interventional radiologists are dedicated to treating patients with diseases affecting the peripheral arteries and veins of the circulatory system.
For questions or more information, contact Dr. Mannava’s office directly at (740) 687-6910.
# # #